Procort Cream
FDA Label NDC 50967-357

13 label sections · Submitted to the FDA by Womens Choice Pharmaceuticals Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Womens Choice Pharmaceuticals Llc for the product Procort (NDC 50967-357). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding spl patient package insert, description:, clinical pharmacology, indications & usage, contraindications, precautions, adverse reactions, overdosage, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Spl Patient Package Insert

Packageinsert (Procort Pi)

Packageinsert (Procort Pi)

Pi2 (Procortpi2)

Pi2 (Procortpi2)

PROCORT ®

Description:

ProCort® is a topical preparation containing hydrocortisone acetate 1.85% and pramoxine hydrochloride 1.15% in a hydrophilic and hydrophobic cream base which contains patented *Invisicare M1 polymer technology.

Active Ingredients: Hydrocortisone Acetate 1.85%, Pramoxine HCL 1.15%

Inactive Ingredients: Polysorbate-60, Poloxamer 124, PVM/MA copolymer VP/Hexadecene copolymer VP/Eicosene copolymer, Tocopheryl acetate, Aminomethyl propanediol, Stearic Acid, Phenoxyethanol, and Sterilized Water.

Topical corticosteroids are anti-inflammatory and anti-pruritic agents. The structural formula, the chemical name, molecular formula and molecular weight for active ingredients are presented below.

Formula (Procort Formula)

Formula (Procort Formula)

Package Label.Principal Display Panel

Label (Updated2018)

Label (Updated2018)

Procort Carton For 60G Ndc 50967-357-60 Rx Only

See product literature for complete information.

Contents: Each gram of ProCort contains 1.85% (18.5 mg) Hydrocortisone acetate and 1.15% (11.5 mg) Pramoxine hydrochloride (HCI). Also contains 6% M1 polymer. Inactive ingredients: Polysorbate-60, Poloxamer 124, PVM/MA copolymer VP/Hexadecene copolymer VP/Eicosene copolymer, Tocopheryl acetate, Aminomethyl propanediol, Stearic Acid, Phenoxyenthanol, and Sterilized Water.

Dosage: Apply to affected are 3 - 4 times daily or as directed by your physician

Warning: Keep out of reach of children. Not fur use under diapers or occlusive dressings without physician supervision. for externam use only. Avoid contact with eyes. May discolor fabrics.

Storage: Store at room temperature 15°-30°C (59°-86°F). Keep tightly closed.

To Open: Remove foil tab or puncture foil seal with cap.

Applicator: Use applicator tip as directed by your physician.

DIRECTIONS FOR RECTAL ADMINISTRATION:

1. To open, remove foil tab or puncture foil seal with cap.

2. Remove the applicator's wrapping and attach the applicator to the tube.

3. Squeeze the tube to fill the applicator and libricate the tip with cream.

4. Gently insert the applicator into rectum and squeeze tube again to force the required amount of cream into rectum.

5. Wipe applicator tip clean, remove and discard.

6. Securely apply screw cap on tube.

NDC 50967-357-60

ProCort 1.85% hydrocortisone acetate - 1.15% pramoxine HCI

FOR EXTERNAL USE ONLY

Net Weight 60.0g (2.12 oz)

Distributed by: Women's Choice Pharmaceuticals, Gilbert, AZ 85233

www.wcpharma.com

877-774-4949

Invisicare® M1 Plymer Patent Numbers: 7,674,471, 6,756,059, 6,582,683

* Please review the disclaimer below.